Anixa Biosciences, Inc. (ANIX) Social Stream



Anixa Biosciences, Inc. (ANIX): $2.77

0.26 (+10.36%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

ANIXA BIOSCIENCES INC (ANIX) Price Targets From Analysts

Use the tables below to see what analysts covering ANIXA BIOSCIENCES INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-27 2 $11 $11 $11 $3.93 179.9%
2022-12-26 2 $11 $8 $9.5 $3.93 141.73%
2023-02-28 1 $11 $11 $11 $3.93 179.9%
2023-03-22 2 $11 $9 $10 $3.93 154.45%
2023-06-16 2 $12 $9 $10.5 $3.93 167.18%
2023-07-28 1 $12 $12 $12 $3.93 205.34%
2023-09-18 1 $12 $9 $10.5 $3.93 167.18%

Price Target Last Issued July 28, 2023

The Trend in the Analyst Price Target


ANIX's average price target has moved down $0.5 over the prior 18 months.

ANIX reports an average of 195.98% for its upside potential over the past 29 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-18 2 12 9 10.5 4.60 128.26%
2023-06-16 1 12 12 12.0 3.40 252.94%
2023-07-28 2 12 12 12.0 3.63 230.58%
2023-07-28 1 12 12 12.0 3.63 230.58%
2023-09-18 1 12 9 10.5 3.38 210.65%

ANIX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


ANIX's average broker recommendation rating improved by 0 over the prior 153 days.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, ANIXA BIOSCIENCES INC's number of analysts covering the stock is higher than 16.98% of them.
  • In terms of how ANIXA BIOSCIENCES INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 32.02% of that group.
  • To contextualize these metrics, consider that out of Healthcare stocks, ANIXA BIOSCIENCES INC's average analyst price target is greater than 167.95% of them.
  • ANIXA BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 591.19% of stocks in the small market cap category.

Stocks similar to ANIXA BIOSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PVCT, RNA, and GBIO.

Is ANIX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!